Update
$Cellectar BioSciences (CLRB.US)$ Cellectar Biosciences Reports High Rate of Complete Remission in Investigator Initiated Phase I Study of Iopofosine in Combination with External Beam Radiotherapy in Recurrent Head and Neck Cancer
4 MINUTES AGO, 6:40 AM EST
VIA GLOBENEWSWIRE
4 MINUTES AGO, 6:40 AM EST
VIA GLOBENEWSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
YYDW : Good news was released, but instead it declined![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Trytosaveabit OP YYDW : Happens! It’s also pretty heavily shorted! More than 10% of FF!
YYDW Trytosaveabit OP : Yes, it doesn't look good
Trytosaveabit OP YYDW : If the buy side would pick up? Could see a decent PI? But it won’t hold if that happens
YYDW Trytosaveabit OP : Still waiting$Eyenovia (EYEN.US)$ OK![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Trytosaveabit OP YYDW : You and me both! Hehehe. GL![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")